Molybdenum oxide nanoparticles (MoOx, NPs) were successfully prepared by the pulsed laser ablation technique in water. Picosecond pulses allowed synthesizing chemically and morphologically stable MoOx colloidal nano-particles dispersed in water, which are used to fabricate modified screen printed carbon paste electrode (SPCE). The molybdenum oxide nanoparticles modified electrode (MoOx NPs/SPCE) shows enhanced electro-catalytic behavior for the detection of dopamine in Phosphate Buffered Saline (pH = 7) solution. Under the optimal conditions, the peak current of dopamine increased linearly with the concentration in the 0.1-600 mu M range, with a limit of detection (LOD) of 43 nM. The very easy MoOx NPs/SPCE fabrication, its high sensitivity, sub-micromolar detection limits and excellent selectivity towards main interferents, made them as a potential candidate for the detection of dopamine in pharmaceutical and clinical preparations.

Molybdenum oxide nanoparticles for the sensitive and selective detection of dopamine

Fazio, E.
Primo
;
Spadaro, S.
Secondo
;
Bonsignore, M.;Leonardi, S. G.;Neri, G.
Penultimo
;
Neri, F.
Ultimo
2018-01-01

Abstract

Molybdenum oxide nanoparticles (MoOx, NPs) were successfully prepared by the pulsed laser ablation technique in water. Picosecond pulses allowed synthesizing chemically and morphologically stable MoOx colloidal nano-particles dispersed in water, which are used to fabricate modified screen printed carbon paste electrode (SPCE). The molybdenum oxide nanoparticles modified electrode (MoOx NPs/SPCE) shows enhanced electro-catalytic behavior for the detection of dopamine in Phosphate Buffered Saline (pH = 7) solution. Under the optimal conditions, the peak current of dopamine increased linearly with the concentration in the 0.1-600 mu M range, with a limit of detection (LOD) of 43 nM. The very easy MoOx NPs/SPCE fabrication, its high sensitivity, sub-micromolar detection limits and excellent selectivity towards main interferents, made them as a potential candidate for the detection of dopamine in pharmaceutical and clinical preparations.
2018
File in questo prodotto:
File Dimensione Formato  
2018_jec_814_91–96.pdf

solo gestori archivio

Descrizione: Articolo principale
Tipologia: Versione Editoriale (PDF)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 766.88 kB
Formato Adobe PDF
766.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3126615
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 43
social impact